UTILIZATION OF GONADOTROPIN-RELEASING HORMONE AGONISTS FOR PRESERVATION OF OVARIAN FUNCTION IN WOMEN WITH BREAST CANCER RECEIVING CHEMOTHERAPY.

被引：0
|
作者：
Vitez, Sally F. [1 ]
Chen, Ling [1 ]
Brady, Paula C. [1 ]
Wright, Jason D. [1 ]
机构：
[1] Columbia Univ, Med Ctr, New York, NY USA
来源：
FERTILITY AND STERILITY | 2019年 / 112卷 / 03期
关键词：
D O I：
10.1016/j.fertnstert.2019.07.412
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-9
引用
收藏
页码：E112 / E112
页数：1
相关论文
共 50 条
  • [11] Ovarian preservation with gonadotropin-releasing hormone analog during chemotherapy
    Gilan, Mitra Modares
    Hasanzadeh, Malihe
    Ghaemmaghami, Faterneh
    Ramazanzadeh, Faterneh
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2007, 3 (02) : 79 - 83
  • [12] The Protective Effects of Gonadotropin-releasing Hormone Agonist on Ovarian Functions in Breast Cancer Patients Receiving Chemotherapy
    Wang, Chen
    Yu, Xing-Fei
    DISCOVERY MEDICINE, 2018, 25 (135) : 7 - 11
  • [13] Gonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: a systematic review and meta-analysis
    Vitek, Wendy S.
    Shayne, Michelle
    Hoeger, Kathleen
    Han, Yu
    Messing, Susan
    Fung, Chunkit
    FERTILITY AND STERILITY, 2014, 102 (03) : 808 - U525
  • [14] Gonadotropin-Releasing Hormone Analog Cotreatment for Preservation of Ovarian Function
    Blumenfeld, Zeev
    ONCOLOGIST, 2012, 17 (02): : 162 - 163
  • [15] Incomplete ovarian function suppression in premenopausal breast cancer patients treated with gonadotropin-releasing hormone agonists
    Lin, Jinna
    Zheng, Shuqi
    Liu, Qiang
    CANCER TREATMENT REVIEWS, 2025, 133
  • [16] Gonadotropin-Releasing Hormone Analog Cotreatment for the Preservation of Ovarian Function during Gonadotoxic Chemotherapy for Breast Cancer: A Meta-Analysis
    Wang, Chuan
    Chen, Minyan
    Fu, Fangmeng
    Huang, Meng
    PLOS ONE, 2013, 8 (06):
  • [17] Gonadotropin-releasing hormone agonists cotreatment during chemotherapy in borderline ovarian tumor and ovarian cancer patients
    ZHU Hong-lan
    WANG Yan
    LI Xiao-ping
    WANG Chao-hua
    WANG Yue
    CUI Heng
    WANG Jian-liu
    WEI Li-hui
    中华医学杂志（英文版）, 2013, 126 (04) : 688 - 691
  • [18] Gonadotropin-releasing hormone agonists cotreatment during chemotherapy in borderline ovarian tumor and ovarian cancer patients
    Zhu Hong-lan
    Wang Yan
    Li Xiao-ping
    Wang Chao-hua
    Wang Yue
    Cui Heng
    Wang Jian-liu
    Wei Li-hui
    CHINESE MEDICAL JOURNAL, 2013, 126 (04) : 688 - 691
  • [19] Ovarian histopathology in premenopausal patients with breast cancer receiving gonadotropin-releasing hormone(GnRH) agonist and/or cytotoxic chemotherapy
    Sato, N
    Sano, M
    Kaneko, K
    Kanbayashi, C
    Honmma, K
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S239 - S239
  • [20] Oncologic Safety of Gonadotropin-Releasing Hormone Agonist for Ovarian Function Protection During Breast Cancer Chemotherapy
    Kim, Hee Jeong
    Lee, Moo Hyun
    Lee, Jeong Eon
    Park, Seho
    Lee, Eun Sook
    Kang, Yong Joon
    Shin, Hae Na
    Kim, Seung Il
    Lee, Jun Ho
    Im, Seock Ah
    Ahn, Sei Hyun
    Lee, Keun Seok
    Sohn, Joohyuk
    Kim, Seonok
    Nam, Seok Jin
    Han, Wonshik
    CLINICAL BREAST CANCER, 2018, 18 (05) : E1165 - E1172
12345